The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

類似資料

• Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
  著者:: Coles, A, 等
  出版事項: (1999)
• Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
  著者:: Coles, A, 等
  出版事項: (1999)
• Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
  著者:: Cox, A, 等
  出版事項: (2005)
• Monoclonal antibodies in multiple sclerosis treatment: current and future steps
  著者:: Claire L. Helliwell, 等
  出版事項: (2009-07-01)
• Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
  著者:: Bindon, C, 等
  出版事項: (1985)